Baicalin inhibits Chlamydia trachomatis growth by impairing elementary body infectivity

Key Points

• Inhibiting Chlamydia trachomatis growth was achieved with baicalin, indicating its therapeutic potential.
• Baicalin treatment led to a significant reduction in elementary body infectivity, underscoring its antiviral effect.
• Assessment using bacteriological analyses showed a notable decrease in organism replication rates after baicalin application.
• This research highlights innovative antibacterial strategies, opening routes for future treatments against infections.